These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2321019)

  • 1. Limit of T cell tolerance to self proteins by peptide presentation.
    Schild H; Rötzschke O; Kalbacher H; Rammensee HG
    Science; 1990 Mar; 247(4950):1587-9. PubMed ID: 2321019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.
    Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactive cytotoxic T cells recognize minor transplantation antigens presented by major histocompatibility complex class Ib molecules.
    Speiser DE; Bachmann MF; Soloski MJ; Forman J; Ohashi PS
    Transplantation; 1998 Sep; 66(5):646-50. PubMed ID: 9753347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice.
    Cook JR; Solheim JC; Connolly JM; Hansen TH
    J Immunol; 1995 Jan; 154(1):47-57. PubMed ID: 7995959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs.
    Li L; Sullivan BA; Aldrich CJ; Soloski MJ; Forman J; Grandea AG; Jensen PE; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3707-15. PubMed ID: 15356116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex.
    Stryhn A; Andersen PS; Pedersen LO; Svejgaard A; Holm A; Thorpe CJ; Fugger L; Buus S; Engberg J
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10338-42. PubMed ID: 8816801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejection.
    Tjoa BA; Kranz DM
    Cancer Res; 1994 Jan; 54(1):204-8. PubMed ID: 7505197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
    Glas R; Ohlén C; Höglund P; Kärre K
    J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I.
    Griffiths E; Ong H; Soloski MJ; Bachmann MF; Ohashi PS; Speiser DE
    Cancer Res; 1998 Oct; 58(20):4682-7. PubMed ID: 9788622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides.
    Zhou X; Abdel Motal UM; Berg L; Jondal M
    Eur J Immunol; 1992 Dec; 22(12):3085-90. PubMed ID: 1446701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.
    Chen BP; Madrigal A; Parham P
    J Exp Med; 1990 Sep; 172(3):779-88. PubMed ID: 2117634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide.
    Heeg K; Kuon W; Wagner H
    Eur J Immunol; 1991 Jun; 21(6):1523-7. PubMed ID: 1904363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
    Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective presentation of endogenous antigen by a cell line expressing class I molecules.
    Hosken NA; Bevan MJ
    Science; 1990 Apr; 248(4953):367-70. PubMed ID: 2326647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular peptide composition governed by major histocompatibility complex class I molecules.
    Falk K; Rötzschke O; Rammensee HG
    Nature; 1990 Nov; 348(6298):248-51. PubMed ID: 2234092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
    Lobigs M; Müllbacher A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.